Evidence map›Paper›PMID 27698860›Full record

ArticleOncology letters2016

Leucine zipper, down regulated in cancer-1 gene expression in prostate cancer.

Michele Salemi, Nunziata Barone, Sandro La Vignera, Rosita A Condorelli, Domenico Recupero, Antonio Galia, Filippo Fraggetta, Anna Maria Aiello, Pietro Pepe, Roberto Castiglione and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Oncology letters, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Michele SalemiLaboratory of Cytogenetics, National Institute for Research and Treatment Oasi Maria SS, Institute for Research on Mental Retardation and Brain Aging, I-94018 Troina, Italy.
Nunziata BaroneDepartment of Clinical and Experimental Medicine, Section of Endocrinology, Andrology and Internal Medicine, University of Catania, I-95123 Catania, Italy.
Sandro La VigneraDepartment of Clinical and Experimental Medicine, Section of Endocrinology, Andrology and Internal Medicine, University of Catania, I-95123 Catania, Italy.
Rosita A CondorelliDepartment of Clinical and Experimental Medicine, Section of Endocrinology, Andrology and Internal Medicine, University of Catania, I-95123 Catania, Italy.
Domenico RecuperoDepartment of Clinical and Experimental Medicine, Section of Endocrinology, Andrology and Internal Medicine, University of Catania, I-95123 Catania, Italy.
Antonio GaliaPathology Unit, Cannizzaro Hospital, I-95100 Catania, Italy.
Filippo FraggettaPathology Unit, Cannizzaro Hospital, I-95100 Catania, Italy.
Anna Maria AielloPathology Unit, Cannizzaro Hospital, I-95100 Catania, Italy.
Pietro PepeUrology Unit, Cannizzaro Hospital, I-95100 Catania, Italy.
Roberto CastiglioneDepartment of Clinical and Experimental Medicine, Section of Endocrinology, Andrology and Internal Medicine, University of Catania, I-95123 Catania, Italy.
Enzo VicariDepartment of Clinical and Experimental Medicine, Section of Endocrinology, Andrology and Internal Medicine, University of Catania, I-95123 Catania, Italy.
Aldo E CalogeroDepartment of Clinical and Experimental Medicine, Section of Endocrinology, Andrology and Internal Medicine, University of Catania, I-95123 Catania, Italy.
University of Catania · ITOspedale Cannizzaro · ITOasi Maria SS · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Numerous genetic alterations have been implicated in the development of prostate cancer (PCa). DNA and protein microarrays have enabled the identification of genes associated with apoptosis, which is important in PCa development. Despite the molecular mechanisms are not entirely understood, inhibition of apoptosis is a critical pathophysiological factor that contributes to the onset and progression of PCa. Leucine zipper, down-regulated in cancer 1 (LDOC-1) is a known regulator of the nuclear factor (NF)-mediated pathway of apoptosis through the inhibition of NF-κB. The present study investigated the expression of the LDOC-1 gene in LNCaP, PC-3, PNT1A and PNT2 prostate cell lines by reverse transcription-quantitative polymerase chain reaction. In addition LDOC-1 protein expression in normal prostate tissues and PCa was studied by immunohistochemistry. LDOC-1 messenger RNA resulted overexpressed in LNCaP and PC-3 PCa cell lines compared with the two normal prostate cell lines PNT1A and PNT2. The results of immunohistochemistry demonstrated a positive cytoplasmic LDOC-1 staining in all PCa and normal prostate samples, whereas no nuclear staining was observed in any sample. Furthermore, a more intense signal was evidenced in PCa samples. LDOC-1 gene overexpression in PCa suggests an activity of LDOC-1 in PCa cell lines.

Indexed as

LDOC-1 geneprostate cancerprotein expressionRT-qPCR

Identifiers

PMID27698860
PMCPMC5038453
OpenAlexW2501586208

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.